-
effectivehealthcare.ahrq.gov/sites/default/files/methodsguidenorris_060420101.pdf
June 01, 2010 - a class
switch to a different drug in the same class. … Food
and Drug Administration and the Center for Medicare and Medicaid Services. … Challenges and opportunities for
pharmacoepidemiology in drug-therapy decision
making. … Drug
Effectiveness Review Project. … Drug class review on the
triptans: Drug Effectiveness Review Project.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-observational-studies_methods.pdf
June 01, 2010 - a class
switch to a different drug in the same class. … Food
and Drug Administration and the Center for Medicare and Medicaid Services. … Challenges and opportunities for
pharmacoepidemiology in drug-therapy decision
making. … Drug
Effectiveness Review Project. … Drug class review on the
triptans: Drug Effectiveness Review Project.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/back-pain-treatment_clinician.pdf
November 01, 2016 - versus placebo; ↔ = no difference between the interventions; NSAID = nonsteroidal anti-inflammatory drug … versus placebo; ↔ = no difference between the interventions;
NSAID = nonsteroidal anti-inflammatory drug … not be ruled out.
�» Clinicians are advised to refer to individual studies in the report or to
the drug … labels of each drug for comprehensive information on their
potential adverse effects. … difference between the interventions;
EMG = electromyography; NSAID = nonsteroidal anti-inflammatory drug
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/insomnia_clinician.pdf
August 01, 2017 - Food and Drug Administration (FDA) has
approved several prescription drugs for insomnia, typically … Drug
General Adult Population Adults 55 Years of Age and Older
Global Outcomes Sleep Outcomesa Global … Food and Drug Administration
(FDA) for insomnia.
d Other benzodiazepines include drugs approved by … Food and Drug Administration Label Information
Drug Class Drug Common Effectsa Serious Effectsb
Nonbenzo … insomnia, nausea
�� Potential impairment of activities requiring complete mental
alertness after drug
-
effectivehealthcare.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
January 01, 2012 - coverage and formulary status of the drug on the
patient’s drug plan … Drug
coverage guidelines. [internet]. … Food and Drug
Administration (FDA); 2011 Apr 5. … Anthem Blue Cross California drug
list. … Drug list search results:
Dificid. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
September 01, 2011 - Food and Drug Administration (FDA) recently
placed a box warning on the entire class of biologic
DMARDs … Health Assessment Questionnaire;
CI = confidence interval; DMARD(s) = disease-modifying anti-rheumatic drug
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/suicidal-thoughts-young-people-appendix-a.pdf
September 26, 2023 - .ti,ab,kf.
5 1 or 2 or 3 or 4
6 Therapeutics/
7 (dm or dt or th).fs.
8 exp Psychotherapy/
9
Drug … therap*" or
"dialectical behavioural therap*" or Digital or dimethyltryptamine or DMT or doximity or
drug … therap*" OR "dialectical behavioural therap*" OR Digital OR
dimethyltryptamine OR DMT OR doximity OR drug
-
effectivehealthcare.ahrq.gov/sites/default/files/s66.pdf
October 01, 2007 - Reform of drug regulation—beyond an indepen-
dent drug-safety board. … The epidemiology of drug treatment failure in rheumatoid
arthritis. … Phar-
macoepidemiol Drug Saf. 2006;15:565–574.
20. Steiner JF, Earnest MA. … Coding accuracy of administra-
tive drug claims in the Ontario Drug Benefit database. … Trends in prescription drug expenditures by
Medicaid enrollees.
-
effectivehealthcare.ahrq.gov/products/arthritis-psoriatric/research
-
effectivehealthcare.ahrq.gov/sites/default/files/functional-limitations-horizon-scan-high-impact-1306.pdf
June 01, 2013 - , the drug
may be cost saving. … MS drug under investigation after 11 deaths. In:
Drug Discovery & Development [internet]. … Anthem Blue Cross California drug list. … Specialty
pharmacy program drug list. … Food and Drug Administration (FDA).
-
effectivehealthcare.ahrq.gov/sites/default/files/s158.pdf
October 01, 2007 - DrPH,*§¶ Jerry Avorn, MD,*
and Sebastian Schneeweiss, MD*�
Background: Nonexperimental studies of drug … effects in large
automated databases can provide timely assessment of real-life drug
use, but are prone … Paradoxical relations of drug
treatment with mortality in older persons. … Colorectal cancer after start of
nonsteroidal anti-inflammatory drug use. … Pharmacoepidemiol Drug Saf. 2006;15:291–303.
10. Angrist JD, Imbens GW, Rubin DB.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1412.pdf
December 01, 2014 - Food and Drug Administration (FDA) approval was based reported that
patients with SBS experienced a … Food and Drug Administration (FDA). FDA
approves Gattex to treat short bowel syndrome. … Food and Drug
Administration (FDA); 2012 Dec 21 [accessed 2013
Jun 05]. [2 p]. … Specialty drug list. [internet]. … Drug
coverage guidelines search: Gattex. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/antidepressants-update_disposition-comments.pdf
December 01, 2011 - It would be better if it
could be divided into 2 reports - one way to do this would be drug
vs drug … Peer Reviewer #5 Methods Pg. 33, line 28 “…and drug interactions.” … 'Drug Interactions' is not really
an outcome measure. … or page 49, line 37-57
Direct evidence was considered sufficient to conduct meta-
analyses for six drug-drug … Might want to say that this is
probably only possible with this specific drug.
-
effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Food and Drug Administration (FDA); 2014
Nov 19. 2 p. … Food and Drug
Administration (FDA); 2014 Nov 19. 3 p. … Food and
Drug Administration; 1993 Nov 19 [accessed
2015 Sep 11]. [2 p]. … Food
and Drug Administration (FDA); 1 p. … Food and Drug Administration; 1992 Nov 24
[accessed 2015 Sep 11]. [2 p].
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_disposition-comments.pdf
December 30, 2015 - Once a
drug is out of patent there is no incentive to finance proper
modern studies. … We included any drug available in the United States if
there were eligible trials. … ‘As needed’ use made insomnia
WORSE on nights the drug was omitted. … on nights the drug is not
taken. … and the placebo group after drug
withdrawal.
-
effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
January 01, 2012 - syringes of the drug at no cost. … MS drug under investigation after 11 deaths. In:
Drug Discovery & Development [internet]. … Specialty
pharmacy program drug list. … MAP Pharmaceuticals resubmits New Drug
Application to FDA for Levadex orally inhaled
migraine drug … Food and Drug Administration (FDA).
-
effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
December 01, 2015 - Food and Drug
Administration (FDA). … Food and Drug Administration (FDA).
510(k) summary for Raisin personal monitor
[K093976]. … Food and Drug Administration (FDA); 2010 Mar
25 [accessed 2010 Dec 27]. [10 p]. … Food and Drug Administration
(FDA); 2012 May 14. 10 p. … FDA accepts first digital medicine New
Drug Application for Otsuka and Proteus Digital
Health.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/pilot-projects-supplementing-white-paper.pdf
December 01, 2024 - and
Drug Holiday
for
Osteoporosis
Fracture
Prevention9
Improve
applicability
of
evidence*; … Benefits and harms of drug
treatments. BMJ. 2004 Jul 3;329(7456):2-3. … Long-
Term Drug Therapy and Drug Holidays for
Osteoporosis Fracture Prevention: A
Systematic Review … Long-
Term Drug Therapy and Drug
Discontinuations and Holidays for
Osteoporosis Fracture Prevention … Should
pregnant women be included in phase IV
clinical drug trials?
-
effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
August 13, 2012 - submits an application to the FDA
for an “investigational new drug.” … in routine clinical care after the
drug is approved for marketing (phase 4). … Intervention What is the intervention of interest (e.g., a drug, device, procedure, or test)? … Coverage Which bisphosphonate drugs should be included on a drug formulary? … Pharmacoepidemiol Drug Saf. 2012 May; 21
Suppl 2:6-12.
12. Normand SL, McNeil BJ.
-
effectivehealthcare.ahrq.gov/products/mhs4-computerized-cds/rapid-research